Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says

Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says

MT newswireMT newswire2026/09/16 15:16
11:16 AM EDT, 09/16/2026 (MT Newswires) -- Solid Biosciences' (SLDB) differentiated approach to Duchenne muscular dystrophy and a "materially different" leadership at the US Food and Drug Administration could support upside, RBC Capital Markets said in a Wednesday note. The investment firm sees differentiation in the company's gene therapy construct, steroid-only prophylactic regimen, safety profile, consistent expression and biomarkers. While the company's gene therapy is yet to demonstrate functional outcomes, RBC said it is optimistic that upcoming data readouts will show meaningful separation from natural history. The company has dosed 53 patients so far, while a randomized, placebo-controlled confirmatory trial is already up and running, according to the note. The investment firm estimates a more than $1 billion peak opportunity for Solid Biosciences' DMD program and said most US patients remain untreated. RBC initiated coverage with an outperform rating and a $18 price target. Price: 8.46, Change: +0.09, Percent Change: +1.08
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The world's top sovereign wealth fund achieves an annual return of 14.2% while warning that high returns in U.S. stocks are unlikely to be sustained.

New Zealand's sovereign wealth fund achieved a 14.2% annual return for the 2026 fiscal year, ranking first among global peer funds. However, the management team promptly issued a warning that recent returns from the U.S. stock market are nearly twice the 20-year annualized average, and that mean reversion pressure should not be overlooked. The fund has lowered its long-term expected annual return from 7.8% to 7.2% and reduced its active risk exposure.

华尔街见闻2026/09/17 02:46

Coca-Cola (KO.US) plans to invest 10 billions USD to strengthen U.S. facilities and logistics infrastructure

Coca-Cola announced on Tuesday that it plans to invest $10 billions in U.S. infrastructure between 2026 and 2030.

智通财经2026/09/17 02:26
Coca-Cola (KO.US) plans to invest 10 billions USD to strengthen U.S. facilities and logistics infrastructure

The yen broke below the 156 mark overnight as the Federal Reserve’s hawkish rate hikes pushed the Bank of Japan to a “high-pressure moment.”

After the Federal Reserve raised interest rates, the Japanese yen fell overnight to 156.42. The market is betting that the Bank of Japan will raise rates by 25 basis points on Friday. If the stance is dovish, the yen could fall further to 158 or even 160.

智通财经2026/09/17 02:21
The yen broke below the 156 mark overnight as the Federal Reserve’s hawkish rate hikes pushed the Bank of Japan to a “high-pressure moment.”